GERMAN DRUG OUTPUT RISES

12 April 1992

The pharmaceutical industry of western Germany increased its production to a significant degree last year, according to the industry association, the BPI.

Based on provisional figures, it is regarded as possible that production in 1991 was more than 30 billion Deutschemarks ($18.3 billion) expressed in value terms, according to the association. Figures available for the first eleven months of last year indicate a 16.5% increase in production of 24.3 billion marks ($14.8 billion) worth of the leading drug products, which account for 85% of total pharmaceutical production.

However, the industry's export surplus has narrowed, according to the BPI, with exports advancing by around 14.3% during the period to reach 12 billion marks ($7.3 billion), compared with a 26.3% increase in imports to 7.7 billion marks ($4.7 billion).

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight